Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease

Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · see citing works

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study: A Randomized Controlled Trial

Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited

Ceriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378 · see citing works

Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease

Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291 · see citing works

Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging

Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · see citing works

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · see citing works

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study

Whitmer, R. A., Gunderson, E. P., Barrett-Connor, E., Quesenberry, C. P., & Yaffe, K. (2005) · BMJ · doi:10.1136/bmj.38446.466238.e0 · Cited by 1,090 · see citing works

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15690-0 · Cited by 1,055 · see citing works

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

Rovio, S., Kåreholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Nissinen, A., & Kivipelto, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70198-8 · Cited by 1,054 · see citing works

Projection of Diabetes Burden Through 2050

Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1936 · Cited by 1,004 · see citing works

Increased Risk of Type 2 Diabetes in Alzheimer Disease

Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950 · see citing works

Insulin and neurodegenerative disease: shared and specific mechanisms

Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830 · see citing works

An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease

Gustafson, D., Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1524 · Cited by 811 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

Inflammatory pathways and insulin action

Hotamisligil, G. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802502 · Cited by 717 · see citing works

Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study

Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort

Luchsinger, J. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.7.635 · Cited by 682 · see citing works

Physical Activity, APOE Genotype, and Dementia Risk: Findings from the Cardiovascular Health Cognition Study

Podewils, L. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi092 · Cited by 675 · see citing works

Obesity, Regional Body Fat Distribution, and the Metabolic Syndrome in Older Men and Women

Goodpaster, B. H., Krishnaswami, S., Harris, T. B., Katsiaras, A., Kritchevsky, S. B., Simonsick, E. M., Nevitt, M., Holvoet, P., & Newman, A. B. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.777 · Cited by 637 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons*

Hong, M., & Lee, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 533 · see citing works

Vascular risk factors, incidence of MCI, and rates of progression to dementia

Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530 · see citing works

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI

den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1235-0 · Cited by 512 · see citing works

A 32-Year Prospective Study of Change in Body Weight and Incident Dementia: The Honolulu-Asia Aging Study

Stewart, R., Masaki, K., Xue, Q.-L., Peila, R., Petrovitch, H., White, L. R., & Launer, L. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.1.55 · Cited by 478 · see citing works

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.

Mehta, Z., Cull, C., STRATTON, I. M., Yudkin, J. S., Jenkinson, C., Fletcher, A., Battersby, C., Holman, R. R., & Turner, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1125 · Cited by 428 · see citing works

Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

Kuusisto, J., Koivisto, K. J., Mykkänen, L. M., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M. (1997) · BMJ · doi:10.1136/bmj.315.7115.1045 · Cited by 426 · see citing works

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial

Simons, M., Schwärzler, F., Lütjohann, D., von Bergmann, K., Beyreuther, K. T., DICHGANS, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 415 · see citing works

Diabetes mellitus and risk of dementia in the Kungsholmen project

Xu, W., Qiu, C., Wåhlin, Å., Winblad, B. G., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 409 · see citing works

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P. J., Wasser, D., Johnson‐Traver, S., Lochhead, J. J., & Ziolwolski, C. (2005) · PubMed · doi:10.1001/archneur.62.5.753 · Cited by 394 · see citing works

Rofecoxib

Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 378 · see citing works

Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia

Quadri, P., Fragiacomo, C., Pezzati, R., Zanda, E., Forloni, G., Tettamanti, M., & Lucca, U. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.114 · Cited by 339 · see citing works

Central Obesity and the Aging Brain

Jagust, W. J., Harvey, D. J., Mungas, D., & Haan, M. N. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1545 · Cited by 314 · see citing works

Diabetes mellitus and the Risk of Dementia, Alzheimer’s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging

MacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313 · see citing works

Acute Hyperglycemia Alters Mood State and Impairs Cognitive Performance in People With Type 2 Diabetes

Sommerfield, A. J., Deary, I. J., & Frier, B. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2335 · Cited by 309 · see citing works

Homocysteine and brain atrophy on MRI of non-demented elderly

den Heijer, T., Vermeer, S. E., Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2002) · Brain · doi:10.1093/brain/awg006 · Cited by 282 · see citing works

Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control

Pfützner, A., Marx, N., Lübben, G., Langenfeld, M. R. W., Walcher, D., Konrad, T., & Forst, T. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.041 · Cited by 268 · see citing works

Weight Loss Precedes Dementia in Community‐Dwelling Older Adults

Barrett-Connor, E. L., Edelstein, S. L., Corey‐Bloom, J., & Wiederholt, W. C. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01362.x · Cited by 266 · see citing works

Similarities between Alzheimer's disease and vascular dementia

Kalaria, R. N. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00256-3 · Cited by 257 · see citing works

Small Vessel Disease and Alzheimer’s Dementia: Pathological Considerations

Kalaria, R. N. (2002) · Cerebrovascular Diseases · doi:10.1159/000049150 · Cited by 243 · see citing works

Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

Curb, J. D., Rodríguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K., Foley, D. J., Blanchette, P. L., Harris, T. B., Chen, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.5.971 · Cited by 231 · see citing works

The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)

Charbonnel, B. H., Dormandy, J., Erdmann, E., Massi‐Benedetti, M., Skene, A. M., & PROactive Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1647 · Cited by 230 · see citing works

Demonstrating the case that AD is a vascular disease: epidemiologic evidence

Launer, L. J. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00364-5 · Cited by 227 · see citing works

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

Sidhu, J. S., Cowan, D., & Kaski, J. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.04.001 · Cited by 197 · see citing works

Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling

Inestrosa, N. C., Godoy, J. A., Quintanilla, R. A., KOENIG, C., & Bronfman, M. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.032 · Cited by 187 · see citing works

Predictive Accuracy of MCI Subtypes for Alzheimer’s Disease and Vascular Dementia in Subjects with Mild Cognitive Impairment: A 2-Year Follow-Up Study

Rasquin, S. M. C., Lodder, J., Visser, P. J., Lousberg, R., & Verhey, F. R. J. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000082662 · Cited by 187 · see citing works

Can Dementia Be Prevented? Brain Aging in a Population-Based Context

Haan, M. N., & Wallace, R. B. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.25.101802.122951 · Cited by 187 · see citing works

Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial

The Diabetes Control and Complications Trial Research Group* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-4-199602150-00001 · Cited by 160 · see citing works

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus

van de Ree, M. A., Huisman, M. V., Princen, H. M. G., Meinders, A. E., & Kluft, C. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00316-7 · Cited by 159 · see citing works

Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender

Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154 · see citing works

The Risk of Dementia among Persons with Diabetes Mellitus: A Population‐Based Cohort Studya

Leibson, C. L., Rocca, W. A., Hanson, V., CHA, R., Kokmen, E., O’Brien, P. C., & Palumbo, P. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48496.x · Cited by 152 · see citing works

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus

Nolan, J. J., Jones, N. P., Patwardhan, R., & Deacon, L. F. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00269.x · Cited by 116 · see citing works

Insulin Resistance in Cognitive Impairment

Geroldi, C., Frisoni, G. B., Paolisso, G., Bandinelli, S., Lamponi, M., Abbatecola, A. M., Zanetti, O. O., Guralnik, J. M., & Ferrucci, L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1067 · Cited by 112 · see citing works

Enhancement of insulin‐stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone

Hällsten, K., Virtanen, K. A., Lönnqvist, F., Janatuinen, T., Turiceanu, M., Rönnemaa, T., Viikari, J. S. A., Lehtimäki, T. J., Knuuti, J. M., & Nuutila, P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01332.x · Cited by 89 · see citing works

Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people

Williams, J. H. H. (2002) · Age and Ageing · doi:10.1093/ageing/31.6.440 · Cited by 89 · see citing works

Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria

OZDEMIR, G., Ozden, M., Kır, H. M., et al. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563053492838 · Cited by 76 · see citing works

VASCULAR DEMENTIA, A NEW BEGINNING

Chui, H. (2000) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70234-6 · Cited by 74 · see citing works

Impact of Antidiabetic Medications on Physical and Cognitive Functioning of Older Mexican Americans with Diabetes Mellitus

Wu, J. H., Haan, M. N., Liang, J., Ghosh, D., Gonzalez, H. M., & Herman, W. H. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(02)00464-7 · Cited by 68 · see citing works

Antidiabetic Drugs Present and Future

Campbell, I. W. (2000) · Drugs · doi:10.2165/00003495-200060050-00004 · Cited by 57 · see citing works

Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis

Claudio Napoli, A., & Palinski, W. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.031 · Cited by 54 · see citing works

Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes.

Sommeijer, D., Macgillavry, M. R., Meijers, J., van Zanten, A. P., Reitsma, P., & ten Cate, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.468 · Cited by 49 · see citing works

ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease

Veurink, G., Fuller, S. J., Atwood, C., & Martins, R. N. (2003) · Annals of Human Biology · doi:10.1080/03014460310001620144 · Cited by 47 · see citing works

Polymorphism in the peroxisome proliferator-activated receptor ? gene influences the risk for Alzheimer?s disease

Brune, S., K�lsch, H., Ptok, U., Majores, M., Schulz, A., Schlösser, R. G. M., Rao, M. L., Maier, W., & Heun, R. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0018-6 · Cited by 43 · see citing works

Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects

Helfenstein, T., Fonseca, F. A. H., Relvas, W. G. M., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.12.002 · Cited by 40 · see citing works

Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes

Araki, A., Hosoi, T., Orimo, H., & Ito, H. (2005) · Metabolism · doi:10.1016/j.metabol.2005.02.001 · Cited by 35 · see citing works

Apolipoprotein E and mortality in African-Americans and Yoruba

Lane, K. A., Gao, S., Hui, S. L., Murrell, J. R., Hall, K. S., & Hendrie, H. C. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5505 · Cited by 26 · see citing works

Steroid-induced elevation of glucose in Alzheimer’s disease: relationship to gender, apolipoprotein E genotype and cognition

Aisen, P. S. S., Berg, J. D., Craft, S., Peskind, E. R., Sano, M., Teri, L. L., Mulnard, R. A., Thomas, R. G., & Thal, L. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00015-x · Cited by 12 · see citing works

Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study

Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · see citing works

Physiology and neurobiology of stress and adaptation: central role of the brain

McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 4,981 · see citing works

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works

Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators

McEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864 · see citing works

Protective and damaging effects of stress mediators: central role of the brain

McEwen, B. S. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/bmcewen · Cited by 1,220 · see citing works

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · see citing works

Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota

Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901 · see citing works

Intranasal insulin improves cognition and modulates β-amyloid in early AD

Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works

Amyloid beta oligomers induce impairment of neuronal insulin receptors

Zhao, W., De Felice, F. G., Fernandez, S., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2008) · The FASEB Journal · doi:10.1096/fj.06-7703com · Cited by 587 · see citing works

How does diabetes accelerate Alzheimer disease pathology?

Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492 · see citing works

Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study

Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eee25f · Cited by 432 · see citing works

Common pathological processes in Alzheimer disease and type 2 diabetes: A review

Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367 · see citing works

Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease

Cao, D., Lu, H., Lewis, T. L., & Li, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703561200 · Cited by 336 · see citing works

Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link

Zhang, Y., Huang, N.-Q., Yan, F., Jin, H., Zhou, S.-Y., Shi, J.-S., & Jin, F. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.11.015 · Cited by 301 · see citing works

The role of G protein-coupled receptors in the pathology of Alzheimer's disease

Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288 · see citing works

Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimerʼs Disease

de la Monte, S. M. (2012) · Drugs · doi:10.2165/11597760-000000000-00000 · Cited by 265 · see citing works

Neuronal IGF‐1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease

Freude, S., Hettich, M. M., Schumann, C., Stöhr, O., Koch, L., Köhler, C., Udelhoven, M., Leeser, U., Müller, M., Kubota, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132043 · Cited by 218 · see citing works

The Alzheimer's disease mitochondrial cascade hypothesis: an update

Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206 · see citing works

Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus

Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15103 · Cited by 151 · see citing works

Redefining neuroendocrinology: Epigenetics of brain-body communication over the life course

McEwen, B. S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.11.001 · Cited by 129 · see citing works

Neuroprotective effects of dietary restriction: Evidence and mechanisms

Pani, G. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.004 · Cited by 103 · see citing works

The Role of GLP-1 in Neuronal Activity and Neurodegeneration

Hölscher, C. (2010) · Vitamins & Hormones · doi:10.1016/b978-0-12-381517-0.00013-8 · Cited by 74 · see citing works

Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration

van Dijk, G., van Heijningen, S., Reijne, A. C., Nyakas, C., van der Zee, E. A., & Eisel, U. L. M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00173 · Cited by 75 · see citing works

Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders

Shaikh, S., Rizvi, S. M. D., Shakil, S., Riyaz, S., Biswas, D., & Jahan, R. (2016) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1319 · Cited by 70 · see citing works

Glycation affects fibril formation of Aβ peptides

Emendato, A., Milordini, G., Zacco, E., Sicorello, A., Dal Piaz, F., Guerrini, R., Thorogate, R., Picone, D., & Pastore, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002275 · Cited by 65 · see citing works

GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH

Li, Q.-X., Gao, H., Guo, Y.-X., Wang, B.-Y., Hua, R.-X., Gao, L., Shang, H.-W., Lu, X., & Xu, J.-D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721198 · Cited by 56 · see citing works

Resistance to Metabolic Actions of Insulin and Its Role in Hypertension

Hall, J. E., Summers, R. L., Brands, M. W., Keen, H. L., & Alonso‐Galicia, M. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.8.772 · Cited by 84 · see citing works

Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology

Wang, C. C. L., Goalstone, M. L., & Draznin, B. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2735 · Cited by 269 · see citing works

[Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat].

Suzuki, M., & Odaka, H. (2003) · PubMed · Cited by 2 · see citing works

Insulin resistance and compensatory hyperinsulinemia

Reaven, G. M., & Tsao, P. S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02982-0 · Cited by 142 · see citing works

Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?

Hegde, V. K., Dhurandhar, N. V., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190808 · Cited by 23 · see citing works